To summarize, perhaps most important, but most difficult to achieve will be commonalties and standardization across trials so that rigorous comparison is possible. Researchers will do well to examine clinical trials in other areas, mimicking those elements that are compatible, avoiding those that are not, and above all, avoiding costly reinvention.
|Original language||English (US)|
|Number of pages||24|
|Journal||NIDA research monograph|
|State||Published - 1997|